New Magnesium Implant Delivers Hydrogen Gas to Treat Arthritis
- Authors
- Wei-Lin Wan, Yu-Jung Lin, Po-Chien Shih, Yu-Ru Bow, Qinghua Cui, Yen Chang, Wei-Tso Chia, Hsing-Wen Sung
- Journal
- Angewandte Chemie International Edition
- Year
- 2018
- DOI
- 10.1002/anie.201806159
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Taiwan
- Health Condition
- Osteoarthritis
- Body System
- Musculoskeletal
TL;DR
Scientists have developed tiny particles that release hydrogen gas to reduce inflammation and slow down the damage in knee arthritis.
Key Finding
Magnesium-containing microparticles injected near arthritic joints in mice released therapeutic levels of hydrogen gas continuously, reducing inflammation and preventing cartilage destruction.
Summary
Researchers developed tiny particles made of magnesium and a biodegradable plastic that can be injected near an arthritic knee to continuously release hydrogen gas directly into the inflamed tissue. In a mouse model of osteoarthritis, this delivery system reduced inflammation and protected cartilage from damage, slowing the progression of the disease.
Practical Takeaway
This early-stage research in mice suggests a novel way to deliver hydrogen gas directly to inflamed joints, potentially overcoming the poor absorption of hydrogen when taken by mouth or inhaled. However, this is a laboratory study in animals only—human safety and effectiveness remain unknown, and this approach is not yet available as a treatment.
Abstract
Inflammation is involved in many human pathologies, including osteoarthritis (OA). Hydrogen (H2) is known to have anti‐inflammatory effects; however, the bioavailability of directly administered H2 gas is typically poor. Herein, a local delivery system that can provide a high therapeutic concentration of gaseous H2 at inflamed tissues is proposed. The delivery system comprises poly(lactic‐co‐glycolic acid) microparticles that contain magnesium powder (Mg@PLGA MPs). Mg@PLGA MPs that are intra‐muscularly injected close to the OA knee in a mouse model can act as an in situ depot that can evolve gaseous H2 continuously, mediated by the cycle of passivation/activation of Mg in body fluids, at a concentration that exceeds its therapeutic threshold. The analytical data that are obtained in the biochemical and histological studies indicate that the proposed Mg@PLGA MPs can effectively mitigate tissue inflammation and prevent cartilage from destruction, arresting the progression of OA changes.